Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
Clinical trial NCT04821765 · COMPLETED
Trial details
- NCT number
- NCT04821765
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2023-06-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.